Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041806 | SCV000065502 | benign | not specified | 2009-07-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041806 | SCV000169734 | benign | not specified | 2011-08-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000041806 | SCV000317198 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000993540 | SCV001146607 | benign | not provided | 2018-11-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001097277 | SCV001253540 | likely benign | Retinitis pigmentosa | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001097278 | SCV001253541 | likely benign | Usher syndrome type 2A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV000993540 | SCV001732134 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001097278 | SCV001750420 | benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000993540 | SCV002562982 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BS1, BS2 |
ARUP Laboratories, |
RCV000993540 | SCV003799537 | benign | not provided | 2023-10-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000993540 | SCV005263716 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001097278 | SCV001452249 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041806 | SCV001959335 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000993540 | SCV001973100 | likely benign | not provided | no assertion criteria provided | clinical testing |